Eloctate 250 Unit

ELOCTATE 250 Unit is a recombinant antihemophilic factor used for treating hemophilia B. This intravenous kit helps manage bleeding episodes and prevent surgical bleeding.

ELOCTATE 250 Unit is primarily used for the control and prevention of bleeding episodes in patients with hemophilia B, a genetic disorder that affects blood clotting. It can also be used to manage bleeding during surgical procedures. This medication is designed to replace the missing clotting factor IX, which is essential for proper blood coagulation.

Common effects of ELOCTATE 250 Unit may include mild to moderate reactions at the injection site, such as redness or swelling. Some users might experience headache, nausea, or dizziness. These effects are generally temporary and should be discussed with a healthcare provider if they persist or worsen.

ELOCTATE 250 Unit should be handled with care, ensuring proper storage and administration as directed. It is important to inform your healthcare provider about any allergies or medical conditions before use. Always follow the prescribed guidelines for intravenous administration to minimize risks.

ELOCTATE 250 Unit may interact with other medications, particularly those that affect blood clotting. It is advisable to consult with a healthcare provider before combining it with other treatments. Alcohol and certain supplements might also influence its effectiveness, so it's best to discuss all current medications with a professional.